CBSA Applauds Advanced Industries Accelerator Grant Recipients
By: Colorado BioScience Association Date: 11/19/2021
Colorado BioScience Association applauds CBSA members and honorees from across our state's innovation ecosystem who were awarded Advanced Industries Accelerator Grants by Colorado’s Office of Economic...
Learn MoreWeekly Policy Update: Qualified Small Business Stock Implications within the Build Back Better Act
By: Colorado BioScience Association Date: 11/19/2021
In addition to the price-setting policies and investment implications related to the capital gains tax rate and IRA provisions, the House version of the Build Back Better...
Learn MoreWeekly Policy Update: CBSA Hosts Ecosystem Briefing and Roundtable Discussion with Belgian Ambassador Jean-Arthur Régibeau
By: Colorado BioScience Association Date: 11/12/2021
This week, CBSA was honored to host a dynamic briefing and roundtable discussion for Belgian Ambassador Jean-Arthur Régibeau. Our community appreciated the opportunity to...
Learn MoreBond Pet Foods Develops The World's First Animal-Free Chicken Protein For Dog And Cat Nutrition
By: Colorado BioScience Association Date: 11/11/2021
Proprietary approach brews chicken protein through biotechnology and fermentation, instead of harvesting conventionally on farm and field Bond Pet Foods, Inc., the Boulder-based company working with b...
Learn MoreCBSA Website Wins National Award
By: Colorado BioScience Association Date: 11/08/2021
The Colorado BioScience Association website recently received national recognition by the w3 Awards organization, which celebrates digital excellence. Our site was honored in the industry association...
Learn MoreWeekly Policy Update: Agreement Reached on Drug Pricing Policies within the Budget Reconciliation Package
By: Colorado BioScience Association Date: 11/05/2021
Late last week, the White House released a framework for the budget reconciliation package, known as the Build Back Better Act. The original package had a total cost of $3.5 trillion. The latest frame...
Learn MoreWeekly Policy Update: New CBSA President & CEO Brings Direct Experience with State and Federal Policy Priorities
By: Colorado BioScience Association Date: 10/29/2021
The CBSA Board of Directors announced the appointment of Elyse Blazevich as our President & CEO on October 27. The Association is fortunate to have som...
Learn MoreColorado BioScience Association Appoints Elyse Blazevich, Medical Device Company Founder and Business Leader, as President & CEO
By: Colorado BioScience Association Date: 10/27/2021
Blazevich Steps into New Role During Period of Significant Momentum for Life Sciences in Colorado Denver – Colorado BioScience Association (CBSA) announces the appointment of medical device company fo...
Learn MoreWeekly Policy Update: Medicare Coverage of Innovative Technology (MCIT) Pathway
By: Colorado BioScience Association Date: 10/22/2021
The Advanced Medical Technology Association (AdvaMed) and the Medical Device Manufacturers Association (MDMA) submitted comments last week to the Centers for Medicare...
Learn MoreClearSight Seeks to Restore Vision and Improve the Quality of Life for Millions
By: Colorado BioScience Association Date: 10/22/2021
ClearSight is developing innovative solutions for ophthalmologists that aim to change the standard of care for many patients. Utilizing a micropattern and patented design, the first intraocular lens C...
Learn More